Refractory autoimmune thrombocytopenic purpura treatment with Rituximab

被引：29
作者：
Patel, K [1 ]
Berman, J [1 ]
Ferber, A [1 ]
Caro, J [1 ]
机构：
[1] Thomas Jefferson Univ Hosp, Dept Med Hematol Oncol, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2001年 / 67卷 / 01期
关键词：
D O I：
10.1002/ajh.1081
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：59 / 60
页数：2
相关论文
共 5 条
  • [1] Rituximab chimeric Anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:: Half of patients respond to a four-dose treatment program
    McLaughlin, P
    Grillo-López, AJ
    Link, BK
    Levy, R
    Czuczman, MS
    Williams, ME
    Heyman, MR
    Bence-Bruckler, I
    White, CA
    Cabanillas, F
    Jain, V
    Ho, AD
    Lister, J
    Wey, K
    Shen, D
    Dallaire, BK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2825 - 2833
  • [2] Mow BM, 1999, BLOOD, V94, p82B
  • [3] PERROTA A, 1999, BLOOD S1, V94, P14
  • [4] Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease
    Ratanatharathorn, V
    Carson, E
    Reynolds, C
    Ayash, LJ
    Levine, J
    Yanik, G
    Silver, SM
    Ferrara, JLM
    Uberti, JP
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 133 (04) : 275 - 279
  • [5] REFF ME, 1994, BLOOD, V83, P435
1